GEMCOVAC-19

  • It is India’s first indigenously developed mRNA COVID vaccine and only third mRNA vaccine to be approved for COVID-19 in the world.
  • Recently, GEMCOVAC-19 got ‘restricted emergency use’ nod for the 18-and-above age group.
  • It was developed at Pune’s Gennova Biopharmaceuticals.
  • It is a two-dose vaccine to be administered intramuscularly 28 days ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

News Snippets